Aimin Zang Selected Research

Aimin Zang Research Topics

Disease

19	Neoplasms (Cancer) 01/2023 - 10/2009
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2016
5	Stomach Neoplasms (Stomach Cancer) 08/2022 - 05/2015
4	Lung Neoplasms (Lung Cancer) 11/2020 - 03/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2018
3	Triple Negative Breast Neoplasms 01/2024 - 10/2020
3	Disease Progression 10/2023 - 10/2022
2	Neoplasm Metastasis (Metastasis) 11/2022 - 11/2022
2	Breast Neoplasms (Breast Cancer) 08/2022 - 02/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Adenocarcinoma of Lung 11/2021
1	Starvation 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Nasopharyngeal Carcinoma 09/2019
1	Malignant Mesothelioma 01/2019
1	Infections 12/2017
1	Lymphatic Metastasis 10/2014

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 01/2024 - 06/2022
4	apatinibIBA 08/2022 - 01/2020
3	icotinibIBA 10/2023 - 01/2020
3	Gefitinib (Iressa)FDA Link 11/2022 - 11/2020
3	Tyrosine Kinase InhibitorsIBA 11/2022 - 06/2022
3	MicroRNAs (MicroRNA)IBA 11/2021 - 05/2015
2	sintilimabIBA 01/2024 - 06/2022
2	aflutinibIBA 11/2022 - 11/2022
2	PlatinumIBA 06/2022 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2009
2	Long Noncoding RNAIBA 11/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 11/2021 - 12/2017
1	regorafenibIBA 01/2024
1	130-nm albumin-bound paclitaxelIBA 01/2024
1	toripalimabIBA 01/2024
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2022
1	camrelizumabIBA 06/2022
1	ErbB Receptors (EGF Receptor)IBA 06/2022
1	Liposomes (Liposome)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Gemcitabine FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	zimberelimabIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 12/2021
1	Competitive Endogenous RNAIBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	Autophagy-Related ProteinsIBA 11/2021
1	Beclin-1IBA 11/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	anlotinibIBA 01/2021
1	penpulimabIBA 01/2021
1	Aurora Kinase AIBA 11/2020
1	Pregnane X ReceptorIBA 10/2020
1	AntigensIBA 02/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	LigandsIBA 01/2020
1	LipidsIBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Circular RNAIBA 01/2020
1	PolymersIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Anticarcinogenic AgentsIBA 01/2020
1	tanshinoneIBA 09/2019
1	Cyclin B1IBA 09/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	polycaprolactoneIBA 01/2018
1	ApelinIBA 12/2017
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 12/2017
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	GenisteinIBA 09/2016
1	Proteins (Proteins, Gene)FDA Link 09/2016
1	rat MIRN27 microRNAIBA 09/2016
1	Thymidine Monophosphate (TMP)IBA 05/2016
1	tetramethylpyrazineIBA 05/2016
1	triptolideIBA 03/2016
1	Interleukin-18 (Interleukin 18)IBA 01/2016
1	SmokeIBA 10/2014

Therapy/Procedure

9	Therapeutics 01/2024 - 01/2018
7	Drug Therapy (Chemotherapy) 01/2024 - 10/2009
1	Immunotherapy 12/2023